��������

Eric Quéméneur is a highly experienced professional in the life sciences field, currently serving as Program Director at Inserm since October 2024. Previously, Eric held the position of Vice President and Chief Scientific Officer at Transgene from October 2014 to October 2024. Eric has an extensive background at CEA - Commissariat à l'énergie atomique et aux énergies alternatives, where tenure included roles such as Director of Research Programs and Industrial Partnerships in Life Sciences, Director of the Corporate Toxicology Program, and Head of the Research Unit in Biochemistry & Toxicology, among others, spanning from January 1990 to September 2014. Early career positions include Associate Research Fellow at the Service de Santé des Armées and Research Associate at Hoechst AG. Eric's educational background includes advanced degrees in Biochimie and Pharmacie from Université Claude Bernard Lyon 1 and an HDR from Pierre and Marie Curie University, coupled with foundational studies at INSA Lyon.